BHVN

NYSEStock

Biohaven Ltd.

$9.99-0.48 (-4.59%)

52-Week Range

$7.79
$31.04

Key Stats

Market Cap

1.1B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.53

Volume

1.2M

Avg Volume

2.5M

Performance

1M

-15.87%

3M

-12.15%

6M

-27.87%

YTD

-8.58%

1Y

-64.88%

3Y

-32.17%

5Y

-87.84%

Price Chart

ETF Exposure

BHVN is held by 70 ETFs

ETFFund NameWeight
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.00%
V3AL.LVanguard ESG Global All Cap UCITS ETF (USD) Distributing0.00%
VTVanguard Total World Stock ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
PreviousPage 2 of 2

About BHVN ETF Exposure

Biohaven Ltd. (BHVN) is held by 70 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.1B, BHVN is a widely held institutional stock. The stock currently trades at $9.99. Investors can gain exposure to BHVN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BHVN, sorted by portfolio weight.